JUDY WOODRUFF: The opioid crisis has left
a huge toll and permanent scar across America
and the lives of many families and individuals.
The Centers for Disease Control has estimated
that as many as 400,000 people died in the
U.S. since the late '90s from prescription
and illegal opioids.
Now the first comprehensive settlement against
a key manufacturer appears to have been reached.
More than 20 states and more than 2,000 cities
and counties have reportedly reached a deal
with Purdue Pharma.
That's the manufacturer of OxyContin.
The case against the company was expected
to go to court next month.
Now, as Amna Nawaz reports, there are some
asking whether this settlement is enough.
AMNA NAWAZ: Judy, to be clear, the deal is
not yet finalized.
But plaintiffs' lawyers and Purdue Pharma
have confirmed they are working on a settlement.
Now, the settlement would reportedly include
a payout of up to $12 billion to states, cities
and counties over a number of years, $3 billion
from the Sackler family directly, which owns
Purdue Pharma.
The Sacklers would also give up control of
Purdue Pharma.
There would be a major change for the company
as well.
Purdue Pharma would declare bankruptcy.
It would then be converted into a public trust
focused on combating the opioid epidemic.
Several attorneys general said this was a
settlement in the best interest of their communities.
But others are against it, including William
Tong, the Connecticut attorney general.
Purdue Pharma's headquarters are in his state.
And he joins us live now.
Attorney General Tong, thank you for being
with us tonight.
Let's just begin with the big question.
Why are you opposed to this tentative settlement?
WILLIAM TONG, Connecticut Attorney General:
Well, thank you for having me here tonight,
Amna.
I'm opposed because the scale and the depth
of the destruction, the pain, the death that
has been caused by Purdue and the Sacklers
far exceeds this purported deal and proposed
deal.
And let's just be clear.
No one, to my knowledge, has offered $12 billion
guaranteed in cash, or $10 billion, for that
matter.
The basis of this is a $3 billion guarantee
from the Sacklers.
And beyond that, we don't know anymore.
And that just doesn't cut it.
The Sacklers have a real opportunity here
and Purdue has an opportunity to make this
right and to begin to meet their obligation
to fund vital investments in addiction science,
treatment, and prevention, because they started
this fire, and they poured gasoline on it.
And instead of trying to help put it out in
all of the states, they're choosing to watch
it burn.
AMNA NAWAZ: Well, let's start with the Sackler
family there.
You mentioned that there is a $3 billion offer
from them as part of this tentative deal.
How much more would you like to see from them?
WILLIAM TONG: I would like to see them meet
their obligation to fund treatment and prevention
and to really start to tackle this problem.
This is, frankly, just a down payment.
And there's so much more to be done.
And we have been very clear about our principles.
And I think that our beliefs are shared by
a number of states that Purdue Pharma and
the Sacklers have to get out of the opioid
business completely, that Purdue Pharma has
to get shut down, that it can't continue as
a going for-profit company.
(CROSSTALK)
AMNA NAWAZ: Well, sir, let me just point out
that -- let me just point out, as part of
the reporting so far, the Sackler family would
give up control of the Purdue Pharma, and
Purdue Pharma would go into bankruptcy.
So, you said you want the Sackler family to
meet their obligation.
What is the number that you are looking for?
When you're in talks with them, and negotiations
are ongoing, how would they meet that obligation,
in your mind?
(CROSSTALK)
WILLIAM TONG: I don't think that's clear that
-- under the terms of what has been reported
on.
And I'm not going to comment on specific negotiations.
But it's clear to me that there has not been
an agreement to shut down Purdue Pharma and
for Purdue management and the Sacklers to
get out of the opioid business completely
in the U.S. and abroad, never to return.
I don't think that that's been offered, and
I don't think that's been agreed upon.
With respect to the dollars, it's just clear
to me that what's been offered isn't sufficient.
And the scale of what is the largest public
health crisis, at least in my lifetime, isn't
met by $3 billion or something approximating
that.
And, certainly, there's been no offer of something
like $10 billion or $12 billion that's been
reported by the press.
Any suggestion that there's an offer of that
size in guaranteed, committed dollars to treatment
and prevention is inaccurate.
AMNA NAWAZ: There are several people who will
say, look, $3 billion is a starting point.
You're not being specific with how much money
you would like to see.
But those same victims and families that you
say need your help, $3 billion would begin
to help.
And this wouldn't end the path for accountability.
There are still several other litigation paths
ahead.
What do you say to that?
WILLIAM TONG: It would -- it would begin to
help, but it doesn't do enough.
And the fact is, Purdue Pharma pled guilty
to federal criminal charges in 2007, and,
after that, Purdue Pharma enabled the Sackler
family to siphon off billions upon billions
of dollars, well north of $3 billion, out
of the company to line their own pockets.
And they prioritized profits and protecting
their own wealth over confronting a crisis
that they led the way on and helped to create
in this country that cost, by the way, more
than 1,000 lives in Connecticut just last
year, and even more this year, and billions
and billions in damages, not just across the
country, but in Connecticut alone.
AMNA NAWAZ: Attorney General Tong, I should
ask you as well, though, even if this doesn't
move ahead, there are several other players
in this field.
And I apologize.
We have less than a minute left.
But there is another trial, a federal trial
in October, including a number of other opioid
manufacturers and distributors and pharmacies.
In other words, this is not the only player.
So why not move with what you can now to get
the money that could be available now, and
then pursue other paths against other players?
WILLIAM TONG: Because in our view, based on
what we know of the billions of dollars that
the Sacklers took out of the company, because
of the tremendous damage that they have done,
and the scope and the scale of the death and
destruction and the pain that came at their
hands, what's been offered so far doesn't
even begin to meet what they owe the people
of Connecticut and the people of this country.
And the damage that they have caused far exceeds
any offer that I have seen.
AMNA NAWAZ: That is Connecticut Attorney General
William Tong joining us tonight.
Thank you very much.
WILLIAM TONG: Thank you.
